1. Home
  2. OVID vs ENVX Comparison

OVID vs ENVX Comparison

Compare OVID & ENVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

BUY

Current Price

$2.35

Market Cap

562.5M

Sector

Health Care

ML Signal

BUY

Logo Enovix Corporation

ENVX

Enovix Corporation

SELL

Current Price

$2.67

Market Cap

629.8M

Sector

Miscellaneous

ML Signal

SELL

Company Overview

Basic Information
Metric
OVID
ENVX
Founded
2014
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
562.5M
629.8M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
OVID
ENVX
Price
$2.35
$2.67
Analyst Decision
Strong Buy
Buy
Analyst Count
10
12
Target Price
$5.92
★ $11.35
AVG Volume (30 Days)
1.4M
★ 6.5M
Earning Date
11-11-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
3.90
★ 40.94
EPS
★ N/A
N/A
Revenue
$7,252,000.00
★ $31,821,000.00
Revenue This Year
N/A
$21.56
Revenue Next Year
N/A
$100.06
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 1181.27
37.91
52 Week Low
$1.18
$2.48
52 Week High
$3.11
$14.21

Technical Indicators

Market Signals
Indicator
OVID
ENVX
Relative Strength Index (RSI) 34.43 35.85
Support Level $2.18 N/A
Resistance Level $2.38 $3.08
Average True Range (ATR) 0.13 0.18
MACD -0.03 0.02
Stochastic Oscillator 6.31 34.45

Price Performance

Historical Comparison
OVID
ENVX

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.

Share on Social Networks: